Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Ratio of metalloproteinases predict diabetic foot ulcer healing

Discussion in 'Diabetic Foot & Wound Management' started by NewsBot, Apr 4, 2008.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing
    M. Muller, C. Trocme, B. Lardy, F. Morel, S. Halimi, P. Y. Benhamou
    Diabetic Medicine 25 (4) , 419–426 2008
     
  2. Admin2

    Admin2 Administrator Staff Member

  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers
    Yu Liu, Danqing Min, Thyra Bolton, Vanessa Nubé, Stephen M. Twigg, Dennis K. Yue and Susan V. McLennan
    Diabetes Care Publish Ahead of Print published online ahead of print October 3, 2008
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers
    Zhihong Lia, Shuqin Guoa, Fang Yaob,Yunliang Zhangb, Tingting Lia
    Journal of Diabetes and its Complications; Available online 26 January 2013
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Effect of Daptomycin on Local Interleukin-6, Matrix Metalloproteinase-9, and Metallopeptidase Inhibitor 1 in Patients With MRSA-Infected Diabetic Foot
    Andreas Ambrosch et al
    International Journal of Lower Extremity Wounds June 2013 vol. 12 no. 2 100-105
     
  6. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes.
    Kim HS, Yoo HS.
    Gene Ther. 2013 Apr;20(4):378-85.
     
  7. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated With Type 2 Diabetes and Diabetic Foot Ulcers
    Kanhaiya Singh, Neeraj K. Agrawal, Sanjeev K. Gupta, Kiran Singh
    International Journal of Lower Extremity Wounds September 16,
     
  8. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Differential Expression of Matrix Metalloproteinase-9 Gene in Wounds of Type 2 Diabetes Mellitus Cases With Susceptible -1562C>T Genotypes and Wound Severity
    Kanhaiya Singh et al
    International Journal of Lower Extremity Wounds June 2014 vol. 13 no. 2 94-102
     
  9. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Neutrophil Associated Lipocalin-2 (NGAL) Is Increased and Associates with Increased MMP-9 Activity in an Implant Model of Diabetic Wound Healing
    MARYAM ABDOLLAHI, SARAH AAMIDOR, TARIA NG, ALIREZA REZAEIZADEH, DANQING MIN, STEPHEN M. TWIGG, SUSAN MCLENNAN
    Presented at the 74th American Diabetes Association Mtg; San Francisco; June 14-17 2014
     
  10. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    High Matrix Metalloproteinase Levels Are Associated With Dermal Graft Failure in Diabetic Foot Ulcers
    Valentina Izzo et al
    International Journal of Lower Extremity Wounds August 8, 2014
     
  11. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  12. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    STUDY ON MATRIX METALLOPROTEINASES IN DIABETIC FOOT ULCER DISEASE
    Julie Susan Sam
    Vol 4, No 3 (2015)
     
  13. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence.
    Lazaro JL et al
    J Wound Care. 2016 May;25(5):277-87
     
  14. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation.
    Ayuk SM et al
    J Diabetes Res. 2016;2016:2897656.
     
  15. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Effectiveness of Negative Pressure Therapy in Diabetic Foot Ulcers with Elevated Protease Activity: A Case Series
    Izzo Valentina, Meloni Marco, Giurato Laura, Ruotolo Valeria, and Uccioli Luigi. Advances in Wound Care. October 2016, ahead of print. doi:10.1089/wound.2016.0700.
    Advances in Wound Care October 20, 2016
     
  16. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The effect of a common antibiotics doxycycline on non-healing chronic wound.
    Xu DH et al
    Curr Pharm Biotechnol. 2017 May 18. doi: 10.2174/1389201018666170519095339
     
  17. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers.
    Li G etal
    Int J Low Extrem Wounds. 2017 Mar;16(1):6-13. doi: 10.1177/1534734617696728.
     
  18. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Biological Activity and Implications of the Metalloproteinases in Diabetic Foot Ulcers
    Claudia Castruita-De la Rosa et al
    Biochemistry, Genetics and Molecular Biology
     
  19. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.
    Nguyen TT et al
    European Journal of Pharmacology [13 Jul 2018]
     
  20. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor that Accelerates Healing.
    Nguyen TT, Ding D, Wolter WR, Perez RL, Champion MM, Mahasenan KV, Hesek D, Lee M, Schroeder VA, Jones JI, Lastochkin E, Rose MK, Peterson CE, Suckow MA, Mobashery S, Chang M.
    J Med Chem. 2018 Sep 13
     
  21. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Wound Fluid Matrix Metalloproteinase-9 as a Potential Predictive Marker for the Poor Healing Outcome in Diabetic Foot Ulcers
    Punyanuch Jindatanmanusan et al
    Pathology Research International; Volume 2018, Article ID 1631325, 5 pages
     
  22. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Matrix metalloproteinase 9 induces keratinocyte apoptosis through FasL/Fas pathway in diabetic wound
    Ying LiangChuan YangYongqing LinYasir ParvizKan SunWei WangMeng RenEmail authorLi Yan
    Apoptosis: 04 April 2019
     
  23. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Targeting MMP-9 in Diabetic Foot Ulcers
    Jeffrey I. Jones, Trung T. Nguyen, Zhihong Peng and Mayland Chang
    Pharmaceuticals 2019, 12, 79;
     
  24. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Swift Downregulation of Gelatinases (MMP-2, MMP-9) in Neuropathic Diabetic Foot Ulcers Treated With Total Contact Cast.
    Alvarez OM et al
    Wounds : a Compendium of Clinical Research and Practice [01 May 2019, 31(5):E39-E41]
     
  25. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
    Fields GB
    Cells. 2019 Aug 27 ;8(9)
     
  26. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Local release of metalloproteinases and their inhibitors after a successful revascularisation procedure
    Raffaele Grande Gioia Brachini Antonio V. Sterpetti Valeria Borrelli Raffaele Serra Francesco Pugliese Giuseppe D'Ermo Elvira Tartaglia Paolo Rubino Andrea Mingoli Paolo Sapienza
    27 October 2019
     
  27. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Efficacy of MMP-inhibiting wound dressings in the treatment of hard-to-heal wounds: a systematic review.
    Dissemond J et al
    J Wound Care. 2020 Feb 2;29(2)
     
  28. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Matrix metalloproteinase 9 induces keratinocyte apoptosis through FasL/Fas pathway in diabetic wound.
    Liang Y et al
    Apoptosis. 2019 Aug;24(7-8):542-551
     
  29. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    High Glucose Activates ERK1/2 to Stabilize AP1 and Increase MMP9 Expression in Diabetic Foot Ulcers
    Jiangli Lang et al
    Exp Cell Res. 2021 Mar 3
     
  30. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Alleviating neuropathy of diabetic foot ulcer by co-delivery of venlafaxine and matrix metalloproteinase drug-loaded cellulose nanofiber sheets: production, in vitro characterization and clinical trial
    Rokhsareh Meamar et al
    Pharmacol Rep. 2021 Apr 7
     
  31. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    A Review: Matrix Metallopeptidase-9 Nanoparticles Targeted for the Treatment of Diabetic Foot Ulcers
    Wakuma Wakene Jifar et al
    J Multidiscip Healthc. 2021 Dec 1;14:3321-3329
     
  32. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Role of matrix metalloproteinases in diabetic foot ulcers: Potential therapeutic targets
    Kang Fu et al
    Front Pharmacol. 2022 Oct 20
     
  33. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Efficiency and Safety of Dextran-PAMAM/siMMP-9 Complexes for Decreasing Matrix Metalloproteinase-9 Expression and Promoting Wound Healing in Diabetic Rats
    Heng-Cong Luo et al
    Bioconjugate Chem. 2022,
     
Loading...

Share This Page